König, Alexander Otto

[["dc.bibliographiccitation.firstpage","4128"],["dc.bibliographiccitation.issue","15_suppl"],["dc.bibliographiccitation.journal","Journal of Clinical Oncology"],["dc.bibliographiccitation.lastpage","4128"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Uhl, Waldemar"],["dc.contributor.author","Ettrich, Thomas Jens"],["dc.contributor.author","Reinacher-Schick, Anke C."],["dc.contributor.author","Algül, Hana"],["dc.contributor.author","Friess, Helmut"],["dc.contributor.author","Kornmann, Marko"],["dc.contributor.author","Koenig, Alexander"],["dc.contributor.author","Ghadimi, Michael"],["dc.contributor.author","Wittel, Uwe A"],["dc.contributor.author","Gallmeier, Eike"],["dc.contributor.author","Wille, Kai"],["dc.contributor.author","Geissler, Michael"],["dc.contributor.author","Schimanski, Carl Christoph"],["dc.contributor.author","Prasnikar, Nicole"],["dc.contributor.author","Tannapfel, Andrea"],["dc.contributor.author","Perkhofer, Lukas"],["dc.contributor.author","Berger, Andreas W."],["dc.contributor.author","Seufferlein, Thomas"],["dc.date.accessioned","2020-12-10T18:41:36Z"],["dc.date.available","2020-12-10T18:41:36Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1200/JCO.2019.37.15_suppl.4128"],["dc.identifier.eissn","1527-7755"],["dc.identifier.issn","0732-183X"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77625"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","NEONAX trial: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer, a phase II study of the AIO pancreatic cancer group (AIO-PAK-0313)—Safety interim analysis."],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]